S-1320-119
Placed on Senate Legislative Calendar under General Orders. Calendar No. 275.
Sponsored by Patty Murray (D-WA)
What it does
This bill would require the Department of Defense (DOD) to coordinate with the Department of Veterans Affairs (VA) to evaluate existing research on menopause and perimenopause among current and former members of the uniformed services. The evaluation would examine gaps in research, the availability of provider training on mid-life women's health, and the availability and use of treatments. DOD would then be required to produce a report that includes a strategic plan to address identified research gaps.
Who benefits
Current and former female members of the uniformed services (Army, Navy, Air Force, Marine Corps, Space Force, Coast Guard, the commissioned corps of the Public Health Service, and the commissioned corps of NOAA) who experience perimenopause or menopause. DOD- and VA-employed healthcare providers who may receive improved training resources. Researchers and academic institutions that could receive future funding or direction based on the strategic plan. Pharmaceutical and medical device companies that develop menopause treatments, who may benefit from increased awareness and uptake within the military health system.
Who is hurt
There are no direct, identifiable groups who would be materially harmed by this bill. DOD and VA staff would bear some administrative burden in conducting the evaluation and producing the report. Taxpayers would bear any costs associated with the study and report, though these are expected to be modest. Other health research priorities within DOD and VA could face indirect competition for staff time and attention.
Supporters argue
Supporters argue that women now make up approximately 17% of active-duty military personnel and a growing share of veterans, yet military health research has historically focused on male physiology. They contend that menopause and perimenopause can significantly affect readiness, retention, and quality of life, and that without a systematic review of existing gaps, DOD and VA cannot effectively address these conditions. A mandated strategic plan, they argue, ensures accountability and moves beyond ad hoc responses to a documented, persistent gap in military women's healthcare.
Opponents argue
Opponents argue that this bill adds a duplicative reporting requirement to agencies already burdened with mandated studies, and that DOD and VA have existing mechanisms — including the Women's Health Research Program — to identify and address research gaps without new legislation. They contend that a study and report mandate, without accompanying appropriations or enforceable treatment standards, may produce a document that sits unused, and that Congress would better serve servicewomen by directly funding research or updating clinical care standards rather than commissioning another strategic plan.
Constitutional context
No significant constitutional issues are raised by this bill. Congress has broad authority under Article I, §8, cls. 12–14 to make rules for the government and regulation of the armed forces, which includes directing DOD and VA to conduct research and reporting activities. This is a routine exercise of that authority.
Checks and balances
Congress gains a reporting mechanism over DOD and VA; the executive branch retains discretion over how the evaluation is conducted and how the strategic plan is implemented, with no enforcement mechanism specified in the bill.
Historical precedent
The Women's Health Equity Act and various NDAA provisions have previously directed DOD and VA to study and report on gaps in women's health research and care, establishing a pattern of congressional mandates in this area.